Halozyme Therapeutics shares owned by Mesirow Financial Investment Management International Equity
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Mesirow Financial Investment Management International Equity
from 13F filings
Historical chart of Mesirow Financial Investment Management International Equity investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Mesirow Financial Investment Management International Equity consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Mesirow Financial Investment Management International Equity
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $638k | 9.5k | 67.30 |
| 2025-09-30 | $702k | 9.6k | 73.34 |
| 2025-06-30 | $498k | 9.6k | 52.02 |
| 2025-03-31 | $667k | 10k | 63.81 |
| 2024-12-31 | $932k | 20k | 47.81 |
| 2024-09-30 | $487k | 8.5k | 57.24 |
| 2024-06-30 | $445k | 8.5k | 52.36 |
| 2024-03-31 | $346k | 8.5k | 40.68 |
More positions owned by Mesirow Financial Investment Management International Equity
View all positions for Mesirow Financial Investment Management International Equity